Marker Therapeutics, Inc. (MRKR)
Market Closed
27 Jul, 20:00
$
1. 22
0
0%
$
13.39M Market Cap
- P/E Ratio
- Div Yield
42,251 Volume
0 Eps
$ 1.22
Previous Close 
Want to track MRKR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Marker Therapeutics, Inc. (MRKR) Statistics
Valuation metrics
Market Cap 13.39M
Enterprise value -1.74M
Trailing P/E (ttm) -1.82
Forward P/E -
PEG ratio -0.03
Price/Sales (ttm) 6.29
Price/Book (mrq) 1.71
Enterprise Value/Revenue -0.83
Enterprise Value/EBITDA 0.16
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 59.23K
Average volume (90 days) 61.79K
Price summary
52-Week low 0.81
52-Week high 2.46
Beta -
50-Day moving average 1.35
200-Day moving average 1.54
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 27 Jan 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -5.2%
Operating margin -5.9%
Operational effectiveness
Return on assets -0.63%
Return on equity -0.73%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.11
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.56
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.77
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 4.79%
Book value per share (mrq) 0.71
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
